4//SEC Filing
LEA LEIV 4
Accession 0001567619-22-021651
CIK 0001626971other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:33 PM ET
Size
7.8 KB
Accession
0001567619-22-021651
Insider Transaction Report
Form 4
LEA LEIV
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-12-14$0.84/sh+4,000$3,364→ 133,238 total(indirect: By IRA) - Purchase
Common Stock
2022-12-13$0.74/sh+30,000$22,275→ 129,238 total(indirect: By IRA)
Holdings
- 149,206(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.7255 to $0.7806, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]These shares are held by Leiv Lea IRA Contributory.
- [F3]These shares are held by Leiv Lea and Deborah Karlson, Trustees of the Karlson Lea Family Trust UTA dated February 11, 1998 (the "Karlson Lea Trust"). Mr. Lea has shared voting, investment and dispositive power over the shares held by the Karlson Lea Trust.
Documents
Issuer
Corvus Pharmaceuticals, Inc.
CIK 0001626971
Entity typeother
Related Parties
1- filerCIK 0000939012
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:33 PM ET
- Size
- 7.8 KB